Terms: = Ovarian cancer AND H3F3B, H3_3A, 3021, ENSG00000132475, P84243, H3_3B, MGC87783, MGC87782, H3F3 AND Treatment
1 results:
1. An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line treatment for ovarian cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021).
Lee SW; Kim YM; Cho CH; Kim YT; Kim SM; Hur SY; Kim JH; Kim BG; Kim SC; Ryu HS; Kang SB
Cancer Res Treat; 2018 Jan; 50(1):195-203. PubMed ID: 28324920
[TBL] [Abstract] [Full Text] [Related]
